SMC CFO Charani says Q2 profit jumped 24% on cost efficiencies. New clinics boost visits. Government revenue under 2% of total. SABIC hospital contract valued at SAR 3.8B over 15 years.
Alpha Score of 40 reflects weak overall profile with moderate momentum, poor value, moderate quality, moderate sentiment.
Specialized Medical Co. (SMC) reported a 24% jump in second-quarter net profit, far outpacing revenue growth of roughly 5%, as cost cuts and a wave of new outpatient clinics boosted earnings.
CFO Hani Charani told Argaam that lower general and administrative and financing expenses, plus reduced sales and marketing costs, drove the improvement. The year-ago period included charges tied to a rebranding initiative, which made the current quarter's comparison easier.
"We have focused on improving operational efficiency across our workforce, operating costs, and supply chain by establishing dedicated committees to renegotiate contracts and reduce procurement costs," Charani said. He added that consolidating shared services across the group will generate further savings as newly opened hospitals come online.
SMC opened 57 new outpatient clinics last year, with most becoming operational in the second half. Their contribution has become increasingly visible during 2026, Charani said. New clinics take time to build a patient base, he noted, as utilization rises through referrals and patient familiarity.
Growth in outpatient visits also feeds inpatient admissions, surgeries and emergency services. The conversion rate from clinic visits to hospital stays runs between 2% and 3%, Charani said, though it varies by hospital depending on case mix and specialty complexity.
The company has boosted capacity without adding square footage. A facility that handled roughly 3,000 patient visits several years ago now serves nearly 8,000, thanks to extended operating hours and better use of space. Some radiology departments already run 24 hours a day.
At one new hospital, SMC is testing a model where each physician gets multiple examination rooms. Nurses handle initial assessments while doctors move between rooms, cutting waiting times and raising productivity, Charani explained.
Demand for healthcare in Saudi Arabia remains strong, supported by population growth, urban expansion in northern Riyadh, and the transfer of beneficiaries from the public to the private sector. New residential developments housing 200,000 to 300,000 residents are creating additional need, he said. Expanding health insurance coverage to government and semi-government employees has also added to the insured pool.
Revenue from government entities accounts for less than 2% of SMC's total, Charani said. That is low compared with some healthcare providers, where government contracts contribute 35% to 40% of revenue. The limited exposure reduces the risk of payment delays and credit loss provisions, he said. SMC chooses to focus on insured patients because returns are stronger than on many government contracts.
Charani commented on the SABIC Specialized Behavioral Care Hospital operating agreement, calling the total project value roughly SAR 3.8 billion over 15 years. The company has not yet determined its annual financial contribution. The contract includes a guaranteed minimum operating capacity; occupancy could ramp quickly or gradually depending on patient referrals. SMC expects to disclose more financial details in the third quarter after discussing accounting treatment with auditors.
Capital expenditure for 2026 remains targeted at about SAR 70 million, unchanged from prior guidance. Spending will go toward renovation projects and replacement of medical equipment including MRI machines and CT scanners. SMC is installing a new MRI in the building where the new outpatient clinics opened, and is adding pharmacy, laboratory and radiology services in the same facility to reduce patient movement. A new cardiac catheterization laboratory is expected to start operations during 2026.
Charani said business activity recovered after a temporary dip caused by geopolitical tensions, during which some patients postponed elective surgeries. Patient volumes have rebounded as conditions eased, with positive momentum continuing through July. He said the company is comfortable with its current performance relative to full-year targets.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.